HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by AdvisorNet Financial Inc

AdvisorNet Financial Inc trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 4.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 687 shares of the company’s stock after selling 35 shares during the period. AdvisorNet Financial Inc’s holdings in HCA Healthcare were worth $206,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. FMR LLC grew its stake in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Franklin Resources Inc. grew its position in HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after buying an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after acquiring an additional 41,190 shares in the last quarter. Janus Henderson Group PLC increased its stake in HCA Healthcare by 12.0% in the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after purchasing an additional 143,995 shares in the last quarter. Finally, Darsana Capital Partners LP boosted its position in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $309.26 on Friday. HCA Healthcare, Inc. has a 1-year low of $276.50 and a 1-year high of $417.14. The business’s 50-day simple moving average is $318.49 and its 200-day simple moving average is $353.11. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $78.34 billion, a P/E ratio of 13.89, a P/E/G ratio of 1.03 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Oppenheimer lifted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, TD Cowen lowered their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

Check Out Our Latest Research Report on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.